✦ LIBER ✦

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

✍ Scribed by Mancini, Michele; Perna, Giampaolo; Rossi, Andrea; Petralia, Antonino

Book ID: 121702991
Publisher: Informa plc
Year: 2010
Tongue: English
Weight: 348 KB
Volume: 11
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656561003747441

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comorbid anxiety disorder does not res

A comorbid anxiety disorder does not result in an excess risk of death among patients with a depressive disorder

✍ Wijnand Laan; Fabian Termorshuizen; Hugo M. Smeets; Marco P.M. Boks; Niek J. de 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 202 KB

An open-label trial of duloxetine in pat

An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder

✍ Kaplan, Alicia; Franzen, Michael D.; Nickell, P. V.; Ransom, Danielle; Lebovitz, 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 643 KB

Does comorbid anxiety or depression affe

Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?

✍ Lawrence A. Labbate; Susan C. Sonne; Carrie L. Randal; Raymond F. Anton; Kathlee 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 100 KB

The association of race, comorbid anxiet

The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder

✍ Chung-Hsuen Wu; Steven R. Erickson; John D. Piette; Rajesh Balkrishnan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 287 KB

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial

The functioning and well-being of patien

The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder

✍ Warren H Schonfeld; Carol J Verboncoeur; Sheila K Fifer; Ruth C Lipschutz; Debor 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 434 KB